May 12, 2026
A cannabis company CEO testified Tuesday as the first witness in Citron Research founder Andrew Left's criminal securities fraud trial, telling a California federal jury that Left published an inaccurate short sale report on his company that quickly tanked its stock even though it appears he lacked the "conviction" of his attack.
April 23, 2025
The founder of trading advice website Citron Research and his investment advisory firm cannot escape the U.S. Securities and Exchange Commission's suit alleging they raked in $20 million by manipulating trading prices, a California federal judge ruled Tuesday, saying the complaint adequately alleges fraud.
October 07, 2024
The founder of Citron Research, a newsletter for short sellers, has asked a California federal court to dismiss the U.S. Securities and Exchange Commission's fraud suit against him and his investment advisory firm, arguing the suit "strategically omits" the disclaimers it accused the founder of not making.
July 26, 2024
Federal prosecutors in California announced the indictment Friday of the founder of popular trading advice website Citron Research, accusing Andrew Left of exploiting his platform to manipulate stock prices and earn $16 million through securities fraud.